Horst & Graben Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
2,248
+5
| +0.2% | +$554 | 0.04% | 147 |
|
|
2025
Q1 | $251K | Buy |
+2,243
| New | +$251K | 0.05% | 136 |
|
|
2023
Q4 | – | Sell |
-4,486
| Closed | -$336K | – | 144 |
|
|
2023
Q3 | $336K | Buy |
4,486
+1,079
| +32% | +$80.9K | 0.08% | 99 |
|
|
2023
Q2 | $263K | Buy |
3,407
+21
| +0.6% | +$1.62K | 0.06% | 108 |
|
|
2023
Q1 | $281K | Buy |
3,386
+22
| +0.7% | +$1.83K | 0.07% | 103 |
|
|
2022
Q4 | $289K | Buy |
3,364
+21
| +0.6% | +$1.8K | 0.08% | 106 |
|
|
2022
Q3 | $206K | Buy |
3,343
+38
| +1% | +$2.34K | 0.06% | 120 |
|
|
2022
Q2 | $204K | Buy |
+3,305
| New | +$204K | 0.06% | 125 |
|
|
2022
Q1 | – | Sell |
-3,227
| Closed | -$234K | – | 140 |
|
|
2021
Q4 | $234K | Buy |
3,227
+30
| +0.9% | +$2.18K | 0.06% | 124 |
|
|
2021
Q3 | $223K | Buy |
3,197
+32
| +1% | +$2.23K | 0.06% | 123 |
|
|
2021
Q2 | $218K | Buy |
3,165
+4
| +0.1% | +$276 | 0.06% | 122 |
|
|
2021
Q1 | $204K | Buy |
+3,161
| New | +$204K | 0.06% | 124 |
|
|
2020
Q3 | – | Sell |
-3,150
| Closed | -$242K | – | 109 |
|
|
2020
Q2 | $242K | Buy |
+3,150
| New | +$242K | 0.11% | 88 |
|